Under the direction of Melissa Kacena, PhD, the Kacena Lab is exploring the interaction of the bone and hematopoietic systems, thereby potentially improving the treatment of metabolic bone disease, hematopoietic disorders and fracture healing.
To achieve this goal, the Kacena Lab focuses on the role of megakaryocytes, megakaryocyte growth factors and their receptors in bone homeostasis; osteoblasts and the hematopoietic stem cell niche; regulators of osteosarcoma tumor growth; translational/clinical studies examining the genetic regulation of skeletal homeostasis; the molecular mechanisms underlying bone repair and fracture healing.
Collaborative Training Environment
Bone Healing in Space
In collaboration with NASA and the U.S. Department of Defense, the Kacena Lab introduced innovative research 250 miles above the Earth’s surface aboard the International Space Station as part of the Rodent Research IV (RR-IV) mission. The goal of RR-IV is to determine the effectiveness of a new drug therapy developed by Dr. Kacena to enhance bone regeneration.
In the weightlessness of space, researchers are able to study novel and current bone healing therapies to translate new discoveries in bone regeneration for osteoporosis, fracture healing and other bone disorders. If successful, this new drug therapy introduced through the RR-IV mission may help expedite the healing process for patients with severely damaged or injured bones.